4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000210
EVP Strategy and Corporate Dev sold 1,531 shares at an average $427.31 ($654,213)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-07-23 | Sale | −200 | $421.62 | $84,323 | 75,739 | D |
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-07-23 | Sale | −100 | $424.50 | $42,450 | 75,639 | D |
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-07-23 | Sale | −437 | $427.21 | $186,691 | 75,202 | D |
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-07-23 | Sale | −211 | $428.10 | $90,328 | 74,991 | D |
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-07-23 | Sale | −583 | $429.54 | $250,421 | 74,408 | D |
| Open-market sales · 1,531 sh · avg $427.31 · $654,213 | |||||||
Loading xslF345X03/edgardoc.xml…